UPDATE 2-U.S. FDA approves Teva's generic of Mylan's EpiPen
August 16, 2018 at 15:09 PM EDT
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.
